Prof. Wouter W de Herder is professor of Endocrine Oncology at the Erasmus MC in Rotterdam, the Netherlands. In this University Hospital he is chairman of a multidisciplinary group for endocrine oncology (tumorwerkgroep endocriene tumoren) and he is head of the ENETS centre of excellence for neuroendocrine tumors. His major research interests are neuroendocrine and endocrine tumors. Professor de Herder received his MD in 1985 and his PhD in 1990 from the Erasmus University in Rotterdam, the Netherlands. He is a member of several international and Dutch national societies, such as the Dutch society for Endocrinology (NVE), the Endocrine Society (USA), the European Society of Endocrinology (ESE), European Neuroendocrine Tumor Society (ENETS) and the North American Neuroendocrine Tumor Society (NANETS). He served as a board member of the Dutch society for Endocrinology (NVE) (2009-2014). He served as chairman (2006-2008) and vice-chairman of ENETS (2008-2010; European Neuroendocrine Tumour Society). He is member of the advisory boards of ENETS and NANETS. Prof. de Herder has (co-)published >400 peer-reviewed papers and book chapters and is a reviewer for many international journals. He is a member of the editorial boards of Neuroendocrinology; Endocrinology, Diabetes & Metabolism Case Reports; Clinical Endocrinology and Endocrine-related Cancer. He is member of the Publishing and Communications Committee of the ESE and Editor of ESE News. Prof. de Herder has given >170 invited presentations at Dutch national and international meetings.

Prof. Wouter de Herder has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AAA, Novartis, Ipsen and Pfizer.